Nyxoah (XBRU:NYXH) Long-Term Debt : €8.62 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Nyxoah Long-Term Debt?

Nyxoah's Long-Term Debt for the quarter that ended in Mar. 2024 was €8.62 Mil.

Nyxoah's quarterly Long-Term Debt declined from Sep. 2023 (€8.41 Mil) to Dec. 2023 (€8.37 Mil) but then increased from Dec. 2023 (€8.37 Mil) to Mar. 2024 (€8.62 Mil).

Nyxoah's annual Long-Term Debt increased from Dec. 2021 (€7.80 Mil) to Dec. 2022 (€8.19 Mil) and increased from Dec. 2022 (€8.19 Mil) to Dec. 2023 (€8.37 Mil).

Nyxoah Long-Term Debt Historical Data

The historical data trend for Nyxoah's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nyxoah Long-Term Debt Chart

Nyxoah Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

7.15

7.61

7.80

8.19

8.37

Nyxoah Quarterly Data
	Dec17	Dec18	Jun19	Dec19	Mar20	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															8.38	8.43	8.41	8.37	8.62

Nyxoah (XBRU:NYXH) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Nyxoah Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Nyxoah's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Nyxoah (XBRU:NYXH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nyxoah SA (XBRU:NYXH) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

NYXH:USA 5YI:Germany

Address

Rue Edouard Belin 12, Mont-Saint Guibert, BEL, 1435

Website

https://www.nyxoah.com

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.